Table 1. Proportion of English GPs with Direct Access to Laboratory and Imaging Tests for Cancer Investigation by Region.
| TEST | ENGLAND | REGION(%) n (%) | p-value | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 511 | ||||||||||||||
| n (%, 95% C.I) | C.Mid | East | Lndn | Manc | N.East | N.Mid | Sth.C | Sth.E | Sth.W | Wessx | W.Mid | YksH | ||
| (N = 34) | (N = 39) | (N = 68) | (N = 14) | (N = 40) | (N = 47) | (N = 63) | (N = 50) | (N = 47) | (N = 30) | (N = 42) | (N = 37) | |||
| Laboratory Testing | ||||||||||||||
| Ca-125 | 507 (99, 98–100) | 34 (100) | 39 (100) | 67 (99) | 14 (100) | 40 (100) | 47 (100) | 61 (97) | 50 (100) | 47 (100) | 30 (100) | 42 (100) | 36 (97) | 0.78 |
| Erythrocyte Sedimentation Rate or Plasma Viscosity | 506 (99, 98–100) | 34 (100) | 39 (100) | 68 (100) | 14 (100) | 40 (100) | 47 (100) | 63 (100) | 50 (100) | 44 (94) | 30 (100) | 42 (100) | 35 (95) | 0.01 |
| Faecal Occult Blood Test | 270 (54, 49–59) | 21 (62) | 22 (56) | 47 (69) | 7 (50) | 17 (42) | 22 (47) | 31 (49) | 17 (34) | 21 (45) | 24 (80) | 24 (57) | 17 (46) | <0.01 |
| Prostate Specific Antigen | 510 (100, 98–100) | 34 (100) | 39 (100) | 68 (100) | 14 (100) | 40 (100) | 47 (100) | 63 (100) | 50 (100) | 47 (100) | 30 (100) | 42 (100) | 36 (97) | 0.23 |
| Serum Protein Electrophoresis | 502 (97, 94–99) | 33 (97) | 38 (97) | 66 (97) | 13 (93) | 39 (98) | 47 (100) | 63 (100) | 50 (100) | 47 (100) | 30 (100) | 41 (98) | 35 (95) | 0.25 |
| Urine Protein Electrophoresis | 465 (89, 84–92) | 30 (88) | 34 (87) | 59 (87) | 11 (79) | 38 (95) | 44 (94) | 60 (95) | 46 (92) | 44 (94) | 27 (90) | 40 (95) | 32 (86) | 0.51 |
| Radiology | ||||||||||||||
| X-Ray | 511 (100, N.E) | 34 (100) | 39 (100) | 68 (100) | 14 (100) | 40 (100) | 47 (100) | 63 (100) | 50 (100) | 47 (100) | 30 (100) | 42 (100) | 37 (100) | N.E. |
| Computed Tomography | 277 (54, 49–59) | 28 (82) | 21 (54) | 24 (35) | 6 (43) | 28 (70) | 19 (40) | 25 (40) | 21 (42) | 34 (72) | 2 (7) | 40 (95) | 29 (78) | <0.01 |
| Magnetic Resonance Imaging | 302 (63, 58–68) | 29 (85) | 15 (38) | 49 (72) | 9 (64) | 24 (60) | 30 (64) | 23 (37) | 23 (46) | 29 (62) | 6 (20) | 40 (95) | 25 (68) | <0.01 |
| Ultrasound | 501 (98, 97–99) | 34 (100) | 36 (92) | 68 (100) | 14 (100) | 40 (100) | 47 (100) | 62 (98) | 47 (94) | 46 (98) | 30 (100) | 41 (98) | 36 (97) | 0.17 |
| Endoscopy | ||||||||||||||
| Gastroscopy | 376 (72, 67–77) | 26 (76) | 33 (85) | 52 (76) | 8 (57) | 33 (82) | 30 (64) | 47 (75) | 31 (62) | 32 (68) | 26 (87) | 27 (64) | 31 (84) | 0.05 |
| Flexible Sigmoidoscopy | 226 (42, 37–48) | 15 (44) | 13 (33) | 28 (41) | 6 (43) | 27 (68) | 19 (40) | 37 (59) | 11 (22) | 25 (53) | 18 (60) | 13 (31) | 14 (38) | <0.01 |
| Colonoscopy | 185 (32, 28–37) | 9 (26) | 16 (41) | 21 (31) | 3 (21) | 22 (55) | 7 (15) | 32 (51) | 13 (26) | 27 (57) | 13 (43) | 10 (24) | 12 (32) | <0.01 |
0–50% shaded red, 51–75% shaded amber, 76–100% shaded green.
N.E.–Not Estimable
Regions: C.Mid—Central Midlands; Manc- Cheshire, Lancashire and Greater Manchester; N.East- Cumbria and North-East; East- East; Lndn-London; N.Mid- North Midlands; Sth.C-South Central; Sth.E- South East; Wessx- Wessex; W.Mid- West Midlands; YksH- Yorkshire and Humber.